In vivo MRI reveals the dynamics of pathological changes in the brains of cathepsin D-deficient mice and correlates changes in manganese-enhanced MRI with microglial activation.

Cathepsin D (CTSD; EC 3.4.23.5) is essential for normal development and/or maintenance of neurons in the central nervous system: its deficiency causes a devastating neurological disorder with severely shortened life span in man, sheep and mouse. Neuropathologically, the CTSD deficiencies are characterized by selective neuronal degeneration, gliosis and accumulation of autofluorescent proteinaceous storage material in neurons. Our aim was to study the dynamics behind the pathological alterations occurring in the brains of CTSD-deficient (CTSD-/-) mice by using in vivo magnetic resonance imaging (MRI) and histology. In order to do this, we measured T(2) signal intensity (SI), apparent diffusion coefficient, area and volume of multiple brain structures from MR images acquired using T(2)-, T(1)- and diffusion-weighted sequences at three time points during disease progression. MRI revealed no differences in the brains between CTSD-/- and control mice at postnatal day 15+/-1 (P15+/-1), representing an initial stage of the disease. In the intermediate stage of the disease, P19(+/-1), SI alterations in the thalami of the affected mice became evident in both T(1)- and T(2)-weighted images. The terminal stage of the disease, P25, was characterized by marked alterations in the T(2) SI, apparent diffusion coefficient and volume of multiple brain structures in CTSD-/- mice. In addition, manganese enhanced high-resolution T(1)-weighted 3D sequences (MEMRI) and histological stainings revealed that the hyperintense signal areas in MEMRI matched perfectly with areas of microglial activation in the brains of CTSD-/- mice at the terminal disease stage. In conclusion, the SI alterations in the thalami of CTSD-/- mice preceded other changes, and the degenerative process was greatly enhanced at the age P19(+/-1), leading to severely reduced brain volume in just 6 days.

[1]  J. Cooper.  Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. , 2003 .

[2]  H M Mitchison,et al.  High resolution MRI reveals global changes in brains of Cln3 mutant mice. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[3]  P. Hof,et al.  A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy , 2005, Neuroscience.

[4]  Darlene Fink-Bennett,et al.  A statistical investigation of normal regional intra-subject heterogeneity of brain metabolism and perfusion by F-18 FDG and O-15 H2O PET imaging , 2006, BMC nuclear medicine.

[5]  D. Norris.  The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment , 2001, NMR in biomedicine.

[6]  J. Kay,et al.  Immunolocalization of cathepsin D in normal and neoplastic human tissues. , 1986, Journal of clinical pathology.

[7]  Michael Scholz,et al.  A new point-based warping method for enhanced and simplified analysis of functional brain image data , 2003, NeuroImage.

[8]  Neil D. Rawlings,et al.  MEROPS: the protease database , 2002, Nucleic Acids Res..

[9]  T. Autti,et al.  Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[10]  P. Saftig,et al.  Cathepsin D deficiency is associated with a human neurodegenerative disorder. , 2006, American journal of human genetics.

[11]  P. Tofts.  Quantitative MRI of the Brain , 2003 .

[12]  T. Autti,et al.  Jansky-Bielschowsky variant disease: CT, MRI, and SPECT findings. , 1992, Pediatric neurology.

[13]  Alan C. Evans,et al.  A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. , 2005, Cerebral cortex.

[14]  G. Johnson,et al.  A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. , 2006, Molecular genetics and metabolism.

[15]  C. Peters,et al.  Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. , 1995, The EMBO journal.

[16]  A. Lehesjoki,et al.  Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. , 2006, Brain : a journal of neurology.

[17]  Apparent diffusion coefficient in the aging mouse brain: a magnetic resonance imaging study. , 2006, Life sciences.

[18]  Qiang Wang,et al.  Application of time series techniques to data mining and analysis of spatial patterns in 3D images , 2004, 2004 IEEE International Conference on Acoustics, Speech, and Signal Processing.

[19]  Neil D. Rawlings,et al.  Handbook of proteolytic enzymes , 1998 .

[20]  J. Cooper,et al.  Hippocampal Pathology in the Human Neuronal Ceroid‐Lipofuscinoses: Distinct Patterns of Storage Deposition, Neurodegeneration and Glial Activation , 2004, Brain pathology.

[21]  H. Huppertz,et al.  Neuroradiological findings in classical late infantile neuronal ceroid-lipofuscinosis. , 1996, Pediatric neurology.

[22]  John Russell,et al.  Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water , 2002, NeuroImage.

[23]  C. Hardy,et al.  A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? , 1987, Medical physics.

[24]  J. Suopanki,et al.  Developmental changes in the expression of neuronal ceroid lipofuscinoses-linked proteins. , 2000, Molecular genetics and metabolism.

[25]  R J Ordidge,et al.  The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging , 2000 .

[26]  T. Autti,et al.  Neuronal ceroid lipofuscinoses in childhood , 2000, Neurological Sciences.

[27]  S. Mole,et al.  CLN7 - Turkish variant late infantile NCL , 1999 .

[28]  A. Häkkinen,et al.  Neuroradiological Findings (MRS, MRI, SPECT) in Infantile Neuronal Ceroid-Lipofuscinosis (Infantile CLN1) at Different Stages of the Disease , 2004, Neuropediatrics.

[29]  J. Chi,et al.  Pleomorphic Xanthoastrocytoma: A Developmental Glioneuronal Tumor with Prominent Glioproliferative Changes , 2004, Journal of Neuro-Oncology.

[30]  T. Autti,et al.  MRI of neuronal ceroid lipofuscinosis , 1996, Neuroradiology.

[31]  P. Marzola,et al.  Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage , 2003, NeuroImage.

[32]  H. Nakanishi,et al.  Involvement of Nitric Oxide Released from Microglia–Macrophages in Pathological Changes of Cathepsin D-Deficient Mice , 2001, The Journal of Neuroscience.

[33]  M. Baumann,et al.  A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration , 2000, The EMBO journal.

[34]  L. Hedlund,et al.  Mechanism of Detection of Acute Cerebral Ischemia in Rats by Diffusion‐Weighted Magnetic Resonance Microscopy , 1992, Stroke.

[35]  M. Haltia.  The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.

[36]  T. Nagaoka,et al.  Astrocytic swelling in the ipsilateral substantia nigra after occlusion of the middle cerebral artery in rats. , 2001, AJNR. American journal of neuroradiology.

[37]  H. Nakanishi,et al.  Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons , 2000, The Journal of Neuroscience.

[38]  H. B. Verheul,et al.  Developmental changes in NMDA-induced cell swelling and its transition to necrosis measured with 1H magnetic resonance imaging, impedance and histology. , 1996, Brain research. Developmental brain research.